• OSMI-1 and O-GlcNAc Research: Evidence and Limits

  2026-10-06

  OSMI-1 is a small-molecule O-GlcNAc transferase inhibitor used to investigate protein O-GlcNAc modification. This overview compares supplier-reported activity with a 2026 preeclampsia study and explains what the evidence does—and does not—support about ferroptosis, trophoblast biology, and broader O-GlcNAcylation research.

• Ceftazidime and the Meaning of Resistance Signals

  2026-10-06

  Ceftazidime is more than a third-generation cephalosporin for susceptibility testing: it can help frame how phenotype, resistance genes, plasmid location, and epidemiology relate. This evidence-focused guide interprets Chen et al.’s Guangdong CREC study without turning findings into laboratory instructions.

• Ertapenem and the New Logic of Resistance Research

  2026-10-05

  Ertapenem is more than a susceptibility-test comparator: it can help translational researchers connect PBP biology, phenotype, pharmacokinetics, and resistance-gene mobility. This thought-leadership perspective interprets recent CREC findings while defining the evidence boundaries for using Ertapenem sodium salt in antibiotic resistance research.

• OTUD3, SLC7A11, and Sunitinib Resistance in ccRCC

  2026-10-05

  A 2025 Cancer Letters study identifies OTUD3-mediated stabilization of SLC7A11 as a mechanistic link between cystine metabolism, ferroptosis suppression, and sunitinib resistance in clear cell renal cell carcinoma. The findings support lipid peroxidation as an important pharmacodynamic and mechanistic readout, while also showing why malondialdehyde measurement should be interpreted alongside molecular and cell-death evidence.

• Nuclear cGAS, Chk2, and L1 Retrotransposition

  2026-10-04

  A 2023 Nature Communications study identifies nuclear cGAS as a suppressor of LINE-1 retrotransposition through a CHK2–cGAS–TRIM41 pathway that destabilizes the L1 protein ORF2p. The work expands cGAS biology beyond cytosolic DNA sensing and provides a mechanistic framework for studying genome integrity in DNA damage, senescence, and cancer research.

• Linezolid Evidence in Antimicrobial Research

  2026-10-03

  A source-grounded overview of Linezolid as an oxazolidinone antimicrobial, covering its ribosomal mechanism, research relevance in resistant Gram-positive infections, evidence quality, assay limitations, and the boundaries of comparison with emerging MmpL3-directed tuberculosis compounds.

• Gut Dysbiosis, NF-κB–IL6–STAT3, and Docetaxel Resistance

  2026-10-02

  Zhong et al. link antibiotic-associated gut dysbiosis to prostate cancer progression and Docetaxel resistance through increased permeability, intratumoral lipopolysaccharide, and NF-κB–IL6–STAT3 signaling. The study combines mouse tumor models, fecal microbiota transplantation, 16S rRNA profiling, mechanistic assays, and patient samples to connect microbiome composition with treatment-relevant disease behavior.

• Carbapenemase Gene Transmission in CREC, 2022–2024

  2026-10-01

  This study integrates gene localization, plasmid conjugation, mobile genetic element profiling, and strain typing to examine carbapenemase dissemination in carbapenem-resistant Enterobacter cloacae across eight Guangdong teaching hospitals. Its findings identify dominant blaNDM-1 carriage, frequent transferability, and multidrug resistance as interconnected priorities for antimicrobial resistance research and hospital infection-control modeling.

• Cefiderocol Activity in Resistant European Non-Fermenters

  2026-10-01

  This European surveillance study directly compared cefiderocol with newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa and Acinetobacter spp., including meropenem-resistant isolates. Cefiderocol retained high in vitro susceptibility across resistant subsets, while genomic findings implicated iron-uptake pathway changes in many cefiderocol-resistant isolates and support parallel susceptibility testing rather than assumptions based on cross-resistance.

• Idoxuridine Workflows for Viral DNA Research

  2026-09-30

  Idoxuridine provides a mechanistically grounded way to interrogate viral DNA synthesis, but reliable results depend on stock handling, matched vehicle controls, and orthogonal genome, infectivity, and cell-health readouts. This workflow also adapts a rapid, reversible perturbation strategy from human neuron research without implying that the pain study validates antiviral activity.

• Cefoperazone Sodium Salt for Resistance Assays

  2026-09-30

  Cefoperazone sodium salt supports reproducible MIC, MBC, β-lactamase stability, and biliary tract infection research workflows. This guide translates comparative antimicrobial evidence into practical assay design, formulation controls, and troubleshooting decisions for gram-negative bacterial resistance studies.

• 5-(N,N-dimethyl)-Amiloride in Endothelial Assays

  2026-09-29

  Use 5-(N,N-dimethyl)-Amiloride hydrochloride to separate Na+/H+ exchanger-dependent pH and sodium flux from downstream endothelial barrier injury. This workflow pairs DMA with moesin, permeability, and signaling readouts for more informative sepsis and cardiovascular research.

• Mouse Neutrophil Cell Isolation Kit for Tumor Assays

  2026-09-29

  Build cleaner neutrophil assays for tumor immunology, cytokine response studies, and mRNA nanovaccine validation. Negative selection removes labeled unwanted cells while leaving target neutrophils untouched, supporting high-purity, function-focused experiments.

• From CRISPR Hits to Host-State Biology in Brucella

  2026-09-28

  A translational framework for moving from host-gene discovery in Brucella infection to experimentally controlled macrophage-state perturbation with SDF-1beta (CXCL12), human recombinant.

• Nitrocefin Assays for β-Lactamase Research

  2026-09-28

  Nitrocefin turns β-lactamase activity into a rapid yellow-to-red signal, making it useful for enzyme characterization and first-pass inhibitor screening. This guide shows how to build a controlled assay, interpret results cautiously, and apply the readout to emerging resistance research such as GOB-38 in Elizabethkingia anophelis.

7993 records 1/533 page Next 12345 下5页 Last page